TP53 and breast neoplasm: The effects of somatic alterations in TP53 have been linked to all stages along the oncogenic timeline of breast tumors; from early tumorigenesis, through growth and development, to distant metastasis (Walerych, Napoli, Collavin, & Del Sal, 2012).